These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25099079)

  • 61. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
    Bowden CL; Vieta E; Ice KS; Schwartz JH; Wang PP; Versavel M
    J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
    Bruce J; Hancock L; Roberg B; Brown A; Henkelman E; Lynch S
    Cogn Behav Neurol; 2012 Sep; 25(3):107-14. PubMed ID: 22960434
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
    Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
    Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment.
    Resnick SM; Matsumoto AM; Stephens-Shields AJ; Ellenberg SS; Gill TM; Shumaker SA; Pleasants DD; Barrett-Connor E; Bhasin S; Cauley JA; Cella D; Crandall JP; Cunningham GR; Ensrud KE; Farrar JT; Lewis CE; Molitch ME; Pahor M; Swerdloff RS; Cifelli D; Anton S; Basaria S; Diem SJ; Wang C; Hou X; Snyder PJ
    JAMA; 2017 Feb; 317(7):717-727. PubMed ID: 28241356
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active Control.
    Lewandowski KE; Sperry SH; Cohen BM; Norris LA; Fitzmaurice GM; Ongur D; Keshavan MS
    J Clin Psychiatry; 2017; 78(9):e1242-e1249. PubMed ID: 29045770
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
    Rapado-Castro M; Dodd S; Bush AI; Malhi GS; Skvarc DR; On ZX; Berk M; Dean OM
    Psychol Med; 2017 Apr; 47(5):866-876. PubMed ID: 27894373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The erythropoietin neuroprotective effect: assessment in CABG surgery (TENPEAKS): a randomized, double-blind, placebo controlled, proof-of-concept clinical trial.
    Haljan G; Maitland A; Buchan A; Arora RC; King M; Haigh J; Culleton B; Faris P; Zygun D
    Stroke; 2009 Aug; 40(8):2769-75. PubMed ID: 19556536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial.
    Miskowiak KW; Petersen JZ; Macoveanu J; Ysbæk-Nielsen AT; Lindegaard IA; Cramer K; Mogensen MB; Hammershøj LG; Stougaard ME; Jørgensen JL; Schmidt LS; Vinberg M; Ehrenreich H; Hageman I; Videbech P; Gbyl K; Kellner CH; Kessing LV; Jørgensen MB
    Eur Neuropsychopharmacol; 2024 Feb; 79():38-48. PubMed ID: 38128460
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study.
    Mansur RB; Ahmed J; Cha DS; Woldeyohannes HO; Subramaniapillai M; Lovshin J; Lee JG; Lee JH; Brietzke E; Reininghaus EZ; Sim K; Vinberg M; Rasgon N; Hajek T; McIntyre RS
    J Affect Disord; 2017 Jan; 207():114-120. PubMed ID: 27721184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.
    Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B
    Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.
    Ott CV; Vinberg M; Bowie CR; Christensen EM; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Sep; 19(1):487. PubMed ID: 30208971
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study.
    Iosifescu DV; Moore CM; Deckersbach T; Tilley CA; Ostacher MJ; Sachs GS; Nierenberg AA
    CNS Neurosci Ther; 2009; 15(4):309-19. PubMed ID: 19889129
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia.
    Chengappa KN; Turkin SR; DeSanti S; Bowie CR; Brar JS; Schlicht PJ; Murphy SL; Hetrick ML; Bilder R; Fleet D
    Schizophr Res; 2012 Dec; 142(1-3):145-52. PubMed ID: 23099060
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is there a difference in subjective experience of cognitive function in patients with unipolar disorder versus bipolar disorder?
    Miskowiak K; Vinberg M; Christensen EM; Kessing LV
    Nord J Psychiatry; 2012 Dec; 66(6):389-95. PubMed ID: 22401272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.